Sara, Roderick R.

HRN: 28-69-07  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/12/2026
03/18/2026
IVTT
600mg
Q8
Infected Wound; Abscess Right Foot
Checking Initial Appropriateness 
03/19/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/19/2026
03/26/2026
IV
1.5mg
Q8hrs
DM FOOT
Checking Initial Appropriateness 
03/23/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/23/2026
03/30/2026
IV
600
Q8h
Infected Wound 600mg IV (4ml) 1 Amp X 3doses Per Day X 7 Days = 21 Amps/quantity
Remove - Pending Acceptance
03/26/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/26/2026
04/01/2026
IV DRIP
750mg
OD
Infected Wound R Foot
Remove - Pending Acceptance
03/28/2026
CLINDAMYCIN 300MG (CAP)
03/28/2026
04/02/2026
PO
300mg
Q8
Cellulitis
Remove - Pending Acceptance
03/28/2026
MUPIROCIN 2%, 15G (TUBE)
03/28/2026
03/29/2026
TOPICAL
2%
Q12
Diabetic Foot
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: